Market Overview

Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS

Share:
Related SRDX
Upcoming Non-Deal Road Shows For Syntel, Franklin Covey And Others
SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeilâ„¢ Drug-Coated Balloon
Related VIVO
Sectors and Stocks To Watch If Hillary Clinton Is Elected
UPDATE: Meridian Bioscience Announces Investment in Oasis Diagnostics; Terms Not Disclosed

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings per share.

The trailing-twelve-month earnings per share at SurModics (NASDAQ: SRDX) is $0.99. SurModics' operating margin for the same period is 34.40%.

The trailing-twelve-month earnings per share at Meridian Bioscience (NASDAQ: VIVO) is $0.91. Meridian Bioscience's revenue for the same period is $188.70 million.

The trailing-twelve-month earnings per share at Abaxis (NASDAQ: ABAX) is $0.84. Abaxis' PEG ratio is 5.15.

The trailing-twelve-month earnings per share at Neogen (NASDAQ: NEOG) is $0.75. Neogen's ROE for the same period is 18.10%.

Posted-In: Diagnostic Substances Industry EPS small-capTrading Ideas

 

Related Articles (ABAX + NEOG)

View Comments and Join the Discussion!